Specialties:
Most Popular Rheumatology Reports:
Rheumatology
Rheumatology is the specialty that treats and diagnoses rheumatic diseases. Surveys and online discussions in this area cover subjects such as market evaluation of gout and the use of Puricase® as a new therapy for refractory gout, and a market evaluation of rheumatoid arthritis therapies which identifies possible future treatment options.Reports that are less than a year old are highlighted in yellow. When you select the report title you will be directed to the report abstract and provided a link for purchasing the report. Reports that are over a year old are free of charge and are not highlighted. When you select the report name you will be taken directly to the report.
| Report Name | Report Type | Specialty | Publish Date | |
|---|---|---|---|---|
| Trends and Forecast of Dental Implant Cases | Survey | Dentistry, Rheumatology | Apr 13, 2008 | PAID REPORT |
| To understand patient volume trends over the past 3 fiscal quarters and to estimate future trends. Understand trends in case starts since January 2007. Quantify impact of the downturn of the national economy on case starts. Estimate volume of... | ||||
| Radiation Oncology Cyberknife Product Assessment and Market Trends | Discussion | Oncology, Rheumatology | Dec 3, 2007 | PAID REPORT |
| To conduct a panel discussion among radiation oncologists to understand current uses of Accuray�s Cyberknife � , the investment in and financing of the equipment, and the marketplace for stereotactic radiosurgery equipment. Examine current uses of Cyberknife � in the head and... | ||||
| Rheumatoid Arthritis Market Evaluation | Survey | Rheumatology | Feb 29, 2007 | FREE |
| Assess the current market for Rheumatoid Arthritis (RA) therapies and identify possible future treatment options. Examine current RA patient populations and treatment options. Determine practice procedures that follow the failure of an anti-TNF therapy. ... | ||||
| Gout Market Evaluation | Discussion | Rheumatology | Nov 7, 2006 | FREE |
| Evaluate perceptions of Puricase� (PEG-uricase), a new therapy for refractory gout. Understand facilitators and barriers to Puricase�s use in the context of allopurinol�s widespread use and febuxostat�s journey to FDA approval Determine impact of potential weaknesses of Puricase ... | ||||
 about us contact us |
 |
| © Panel Intelligence, LLC. 1999-2008. All rights reserved. A wholly owned subsidiary of MCF Corporation (NASDAQ: MERR) Privacy Policy |